D. E. Shaw & Co. Inc. Trims Stock Position in FIGS, Inc. (NYSE:FIGS)

D. E. Shaw & Co. Inc. reduced its stake in shares of FIGS, Inc. (NYSE:FIGS - Free Report) by 48.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 335,607 shares of the company's stock after selling 311,476 shares during the quarter. D. E. Shaw & Co. Inc. owned about 0.20% of FIGS worth $2,077,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Barclays PLC grew its position in FIGS by 152.5% during the 3rd quarter. Barclays PLC now owns 286,974 shares of the company's stock worth $1,963,000 after purchasing an additional 173,316 shares during the last quarter. Sugar Maple Asset Management LLC purchased a new position in FIGS during the 4th quarter worth $43,000. Blue Trust Inc. grew its position in FIGS by 380.0% during the 4th quarter. Blue Trust Inc. now owns 7,407 shares of the company's stock worth $51,000 after purchasing an additional 5,864 shares during the last quarter. Consolidated Portfolio Review Corp purchased a new position in FIGS during the 4th quarter worth $179,000. Finally, Lane & Associates LLC purchased a new position in FIGS during the 4th quarter worth $86,000. 92.21% of the stock is currently owned by institutional investors and hedge funds.

FIGS Trading Down 2.8%

Shares of NYSE:FIGS traded down $0.13 during midday trading on Friday, hitting $4.40. The stock had a trading volume of 1,217,433 shares, compared to its average volume of 2,757,220. FIGS, Inc. has a 1 year low of $3.57 and a 1 year high of $7.06. The stock has a 50 day moving average price of $4.34 and a two-hundred day moving average price of $5.07. The company has a market capitalization of $714.28 million, a PE ratio of 73.25, a P/E/G ratio of 31.62 and a beta of 1.20.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on FIGS. Morgan Stanley lowered their target price on shares of FIGS from $4.75 to $4.25 and set an "equal weight" rating on the stock in a report on Thursday, April 17th. Telsey Advisory Group reaffirmed a "market perform" rating and issued a $5.00 target price on shares of FIGS in a report on Tuesday, May 13th. Barclays reaffirmed a "positive" rating on shares of FIGS in a report on Tuesday, May 13th. Finally, The Goldman Sachs Group lowered their target price on shares of FIGS from $4.25 to $3.75 and set a "sell" rating on the stock in a report on Tuesday, April 22nd.

About FIGS

FIGS, Inc operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel.